Core Patient-Reported Outcomes for Trials in Nephrology

Semin Nephrol. 2024 May-Jul;44(3-4):151549. doi: 10.1016/j.semnephrol.2024.151549. Epub 2024 Sep 16.

Abstract

The outcomes reported in trials across all stages of chronic kidney disease (CKD) are highly variable and often do not include outcomes that are directly relevant to patients and caregivers. Frequently, the outcomes reported in trials are often unvalidated surrogate biochemical end points. The omission of outcomes that are meaningful and important to patients can diminish the value of trials in supporting treatment decisions. In response, there have been increasing efforts across many health and medical disciplines to develop core outcome sets, defined as the minimum set of outcomes to be reported in all trials in a specific health area to improve the relevance and consistency of reporting trial outcomes. The international Standardized Outcomes in Nephrology (SONG) initiative was established in 2014 and has since developed seven core outcome sets for different diagnosis and treatment stages of CKD. The core outcomes were based on consensus among patients, caregivers, and health professionals. Each core outcome set includes at least one patient-reported outcome, including fatigue (hemodialysis), life participation (kidney transplantation, peritoneal dialysis, early CKD not yet requiring kidney replacement therapy, children and adolescents, and glomerular disease), and pain (polycystic kidney disease). This article outlines how patient-reported outcomes are currently reported in trials, discusses core patient-reported outcomes that have been established for trials in kidney disease, and outlines strategies for implementing core patient-reported outcomes in trials.

Keywords: Patient-reported outcomes; core outcomes; patient perspectives; trials.

Publication types

  • Review

MeSH terms

  • Clinical Trials as Topic
  • Fatigue / etiology
  • Fatigue / therapy
  • Humans
  • Kidney Transplantation
  • Nephrology*
  • Pain
  • Patient Reported Outcome Measures*
  • Quality of Life
  • Renal Dialysis
  • Renal Insufficiency, Chronic* / therapy